Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oncternal Therapeutics, Inc. - Common Stock (NQ:ONCT)

0.5266 UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.5266
Bid (Size) 0.5700 (1)
Ask (Size) 0.6105 (1)
Prev. Close 0.5266
Today's Range 0.5266 - 0.5266
52wk Range 0.5266 - 9.880
Shares Outstanding 58,711,451
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gold Down Over 3%; Rigetti Computing Shares Spike Higher
Via Benzinga

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-57.9%
-57.9%
1 Year
-94.1%
-94.1%

More News

Read More
Crude Oil Down 3%; Chicago Fed National Activity Index Falls In October
Via Benzinga
Topics Economy
Exposures Fossil Fuels Interest Rates
Dow Surges Over 300 Points; Bath & Body Works Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Recap: Oncternal Therapeutics Q4 Earnings
Via Benzinga
Oncternal Therapeutics's Earnings: A Preview
Via Benzinga
Dow Surges Over 100 Points; ModivCare Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Surges 3%; Kroger Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
US Stocks Mixed; Producer Prices Increase In August
Via Benzinga
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Insiders Buying Westlake Chemical Partners And 2 Other Stocks
Via Benzinga
ONCT Stock Earnings: Oncternal Therapeutics Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Top 5 Health Care Stocks That May Crash This Month
Via Benzinga
Earnings Scheduled For March 7, 2024
Via Benzinga
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Rises Over 3%; US Home Prices Increase In October
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level
Via Benzinga
Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities

Frequently Asked Questions

Is Oncternal Therapeutics, Inc. - Common Stock publicly traded?
Yes, Oncternal Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Oncternal Therapeutics, Inc. - Common Stock trade on?
Oncternal Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Oncternal Therapeutics, Inc. - Common Stock?
The ticker symbol for Oncternal Therapeutics, Inc. - Common Stock is ONCT on the Nasdaq Stock Market
What is the current price of Oncternal Therapeutics, Inc. - Common Stock?
The current price of Oncternal Therapeutics, Inc. - Common Stock is 0.5266
When was Oncternal Therapeutics, Inc. - Common Stock last traded?
The last trade of Oncternal Therapeutics, Inc. - Common Stock was at 12/02/24 04:00 PM ET
What is the market capitalization of Oncternal Therapeutics, Inc. - Common Stock?
The market capitalization of Oncternal Therapeutics, Inc. - Common Stock is 30.92M
How many shares of Oncternal Therapeutics, Inc. - Common Stock are outstanding?
Oncternal Therapeutics, Inc. - Common Stock has 31M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.